LENFOMALI HASTALARDA KEMOTERAPİNİN YAŞAM KALİTESİNE ETKİSİ

Abstract

Amaç: Kemoterapideki gelişmeler lenfomalı hastaların yaşam sürelerini önemli derecede uzatmıştır ve önemli sayıda hasta tedavi edilebilmektedir. Kemoterapi alan hastaların yaşam kalitelerinin değerlendirilmesi giderek daha fazla ilgi çeken bir konu olmuştur. Çalışmamızın amacı, lenfomalı hastalarda kemoterapinin yaşam kalitesine etkilerini değerlendirmektir. Gereç ve Yöntem: Haziran 2000-Ocak 2001 tarihleri arasında Çukurova Üniversitesi Tıp Fakültesi Onkoloji Bilim Dalı’nda Evre I lenfoma tanısı alan 49 hastaya kemoterapi öncesinde ve 2. kür sonrasında yaşam kalitesi anketi (EORTC QLQ C-30) uygulandı. Bulgular: Fiziksel aktivitelerin bazılarında, duygusal fonksiyonlar, ağrı ve halsizlik, dispne, iştahsızlık, uyku ve global yaşam kalitesinde tedavi sırasında anlamlı iyileşme saptandı. Kemoterapi, yaş, cinsiyet ve lenfoma tipi göz önüne alındığında, global yaşam kalitesini etkileyen en önemli faktör hastanın eğitim durumuydu. Sonuç: Çalışmamızın sonuçları, kemoterapi öncesindeki yaşam kalitesine kıyasla tedavi sonrası yaşam kalitesinde iyileşme olması nedeniyle, kemoterapi alma konusunda isteksiz olan hastalara yardımcı olmada kullanılabilir.

Anahtar Kelimeler: Lenfoma, Yaşam kalitesi, EORTC QLQ C-30, Adana

Keywords

• -

References

1. Guyatt G, Veldhuyzen Van Zanten S, Feeny D, Patrick
2. D. Measuring quality of life in clinical trials: a taxonomy
3. and review. Can Med Assoc J 1989; 140: 1441-1448.
4. Lauper P, Versteegen U. The importance of quality of
5. life in policy decisions: new end points in medical
6. outcome assessment. Pharm Med 1992; 5: 43-50.
7. Schumacher A, Kessler T, Riedel A, Buchner T, van de
8. Loo J. Quality of life and coping with illness in patients

9. with acute myeloid leukemia. Psychother Psychosom
10. Med Psychol 1996; 46: 385-390.
11. Jerkeman M, Kaasa S, Hjermstad M, Kvaloy S,
12. Cavallin-Stahl E. Health-related quality of life and its
13. potential prognostic implications in patients with
14. aggressive lymphoma: a Nordic Lymphoma Group Trial.
15. Medical Oncology 2001; 18: 85-94.
16. Persson L, Larsson G, Ohlsson O, Hallberg IR. Acute
17. leukemia or highly malignant lymphoma patients’
18. quality of life over two years: a pilot study. Eur J of
19. Cancer Care 2001; 10: 36-47.
20. Cella DF, Tulsky S. Measuring quality of life today:
21. methodological aspects. Oncology 1990; 4: 29-38.
22. The WHOQOL Group. The World Health Organization
23. quality of life assessment (WHOQOL): position paper
24. from the World Health Organization. Soc Sci Med 1995;
25. : 1403-1409.
26. Gotay CC, Korn EL, McCabe MS, Moore TD, Cheson
27. BD. Quality-of-life assessment in cancer treatment
28. protocols: research issues in protocol development. J
29. Natl Cancer Inst 1992; 84: 575-579.
30. Cella DF. Quality of life: the concept. J Palliat Care
31. ; 8: 8-13.
32. Kaasa S, Loge JH. Quality of life in palliative care:
33. principles and practice. Palliat Med 2003; 17: 11-20.
34. Wierzbicka M, Kusnierkiewicz M, Wojtowicz JG,
35. Maune S, Szyfter W. The quality of life in head and neck
36. cancer patients: description of randomized examination
37. formula based on standardized questionnaires EORTC
38. QLQ C-30, EORTC QTQ-H-N35 and Kiel
39. Questionnaire. Otolaryngol Pol 2001; 55: 287-292 [in
40. Polish].
41. Kaasa S, Bjordal K, Aaronson N, et al. The EORTC
42. core quality of life questionnaire (QLQ-C30): validity
43. and reliability when analyzed with patients treated with
44. palliative radiotherapy. Eur J Cancer 1995; 31A: 2260-
45. -
46. Kobayashi K, Takeda F, Teramukai S, et al. A crossvalidation
47. of the European Organization for Research
48. and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30)
49. for Japanese with lung cancer. Eur J Cancer 1998; 34:
50. –815.
51. Osoba D, Aaronson N, Zee B, Sprangers M, te Velde A.
52. Modification of the EORTC QLQ-C30 (version 2.0)
53. based on content validity and reliability testing in large
54. samples of patients with cancer. The Study Group on
55. Quality of Life of the EORTC and the Symptom Control
56. and Quality of Life Committees of the NCI of Canada
57. Clinical Trials Group. Qual Life Res 1997; 6: 103-108.
58. Aaronson NK, Ahmedzai S, Bergman B, et al. The
59. European Organization for Research and Treatment of
60. Cancer QLQ-C30: a quality-of-life instrument for use in
61. international clinical trials in oncology. J Natl Cancer
62. Inst 1993; 85: 365-376.
63. Bjordal K, Ahlner-Elmqvist M, Tollesson E, et al.
64. Development of a European Organization for Research
65. and Treatment of Cancer (EORTC) questionnaire
66. module to be used in quality of life assessments in head
67. and neck cancer patients. EORTC Quality of Life Study
68. Group. Acta Oncol 1994; 33: 879-885.
69. Bjordal K, de Graeff A, Fayers PM, et al. A 12 country
70. field study of the EORTC QLQ-C30 (version 3.0) and
71. the head and neck cancer specific module (EORTC
72. QLQ-H&N35) in head and neck patients. EORTC
73. Quality of Life Group. Eur J Cancer 2000; 36: 1796-
74. -
75. Blazeby JM, Alderson D, Winstone K, et al.
76. Development of an EORTC questionnaire module to be
77. used in quality of life assessment for patients with
78. oesophageal cancer. The EORTC Quality of Life Study
79. Group. Eur J Cancer 1996; 32A: 1912-1917.
80. Sprangers MA, Cull A, Groenvold M, Bjordal K,
81. Blazeby J, Aaronson NK. The European Organization
82. for Research and Treatment of Cancer approach to
83. developing questionnaire modules: an update and
84. overview. EORTC Quality of Life Study Group. Qual
85. Life Res 1998; 7: 291-300.
86. Schumacher A, Kessler T, Buchner T, Wewers D, van
87. de Loo J. Quality of life in adult patients with acute
88. myeloid leukemia receiving intensive and prolonged
89. chemotherapy-a longitudinal study. Leukemia 1998; 12:
90. -592.
91. Ruffer JU, Flechtner H, Tralls P, et al. Fatigue in longterm
92. survivors of Hodgkin‘s lymphoma; a report from
93. the German Hodgkin Lymphoma Study Group (GHSG).
94. Eur J Cancer 2003; 39: 2179-2186.
95. Vogelzang NJ, Breitbart W, Cella D, et al. Patient,
96. caregiver, and oncologist perceptions of cancer-related
97. fatigue: results of a tripart assessment survey. The
98. Fatigue Coalition. Semin Hematol 1997; 34: 4-12.
99. Curt GA. The impact of fatigue on patients with cancer:
100. overview of FATIGUE 1 and 2. Oncologist 2000; 5
101. (Suppl 2): 9-12.